- Business
- Edinburgh Worldwide Investment Trust plc (EWI.L) is a United Kingdom-based closed-end investment trust managed by Baillie Gifford & Co. Limited that seeks long-term capital growth through a concentrated portfolio of global smaller companies, including both publicly listed and private businesses at the frontiers of technological innovation and transformation; investments span sectors such as biotechnology, software, healthcare equipment and supplies, life sciences tools and services, healthcare technology, pharmaceuticals, semiconductors and semiconductor equipment, aerospace and defense, industrials, and electronic equipment, instruments and components, with top holdings including Space Exploration Technologies, Alnylam Pharmaceuticals, PsiQuantum, AeroVironment, and American Superconductor Corp. The Trust targets emerging growth companies offering significant disruptive potential over a minimum five-year horizon, typically with market capitalizations no larger than the largest constituent of the S&P Global Small Cap Index at initial investment, and maintains high active share relative to its benchmark. It operates geographically worldwide, with substantial exposure to North America, and is listed on the London Stock Exchange as a constituent of the FTSE 250 Index. Incorporated in 1998 and headquartered at Calton Square, 1 Greenside Row, Edinburgh EH1 3AN, Scotland, the Trust has no employees and outsources investment management to Baillie Gifford. In November 2024, the Board announced a strategic reset including reaffirmation of its growth-oriented mandate, portfolio rebalancing toward fewer holdings in more profitable cash-generative companies with enhanced sectoral diversification, a share buyback and capital return program of up to GBP 130 million, and a commitment to limit the discount to net asset value to single digits; this followed collaboration with external specialists and addressed prior underperformance. More recently, in late November 2025, the Trust proposed a merger with Baillie Gifford US Growth Trust plc, though the tie-up faced opposition from activist shareholder Saba Capital Management, which requisitioned a general meeting in December 2025 to remove incumbent directors and appoint new ones amid ongoing performance debates; a requisitioned general meeting and AGM occurred on 14 February 2025. The Trust delivered NAV total return of +16.8% over the year to late 2025, outperforming the S&P Global Small Cap Index (+6.2%), from a more resilient portfolio positioned for future growth.